Big Gain For Clovis Oncology, Inc.

Fri, Jun 17, 2022 at 05:33 PM

Clovis Oncology, Inc. (CLVS:NASDAQ) rocketted at $1.18, representing a gain of 31.9%. The stock got featured on our News Catalysts scanner on Thu, Jun 16, 2022 at 07:32 PM in the 'BIOTECH' category. From Thu, Jun 02, 2022, the stock recorded 60.00% Up Days and 45.45% Green Days

The stock spiked on Tue, Jun 14, 2022 at $1.12 with a volume of 64M+.

About Clovis Oncology, Inc. (CLVS:NASDAQ)

Clovis Oncology Inc is a biopharmaceutical company focused on acquiring, developing and commercializing cancer treatments in the United States, Europe and other international markets.

Top 10 Gainers:

RISE Education Cayman Ltd (REDU:NASDAQ), 138.46%
Revlon, Inc. (REV:NYSE), 91.28%
Mereo BioPharma Group plc (MREO:NASDAQ), 62.5%
SoundHound AI Inc. (SOUN:NASDAQ), 49.81%
Swvl Holdings Corp (SWVL:NASDAQ), 35.29%
Clovis Oncology, Inc. (CLVS:NASDAQ), 31.87%
Jupiter Wellness Inc. (JUPW:NASDAQ), 31.43%
Satellogic Inc. (SATL:NASDAQ), 29.56%
Electric Last Mile Solutions Inc. (ELMS:NASDAQ), 29.43%
Sesen Bio, Inc. (SESN:NASDAQ), 29.21%